Results 251 to 260 of about 345,095 (348)
Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study. [PDF]
Sridharan K.
europepmc +1 more source
Abstract Oral Squamous Cell Carcinoma (OSCC) is the most prevalent form of oral cancer, constituting over 90% of reported cases. This malignancy commonly infiltrates bone, making bone invasion a significant clinical issue. OSCC may invade bone via either an infiltrative or erosive pattern, with the pattern of invasion closely correlating with the ...
Smrithy Sivadas K+4 more
wiley +1 more source
Efficacy of Short-Term Timed Artificial Insemination Protocols With Estradiol Esters and PGF2α in Girolando Cows. [PDF]
Dos Santos Dutra Okada M+4 more
europepmc +1 more source
Iguratimod alleviated Sjögren's syndrome through regulating macrophage polarization
Nonobese diabetic (NOD) mice exhibited characteristic of Sjögren's syndrome (SS), with increased M1 macrophages and deceased M2 macrophages. Iguratimod alleviated SS‐like symptoms and restored balance of macrophage polarization through inhibiting the mitogen‐activated protein kinases pathway in NOD mice.
Junqiao Guo+7 more
wiley +1 more source
Simplified synthesis of oxidized phospholipids on alkyl-amide scaffold. [PDF]
Oskolkova OV, Gesslbauer B, Bochkov V.
europepmc +1 more source
Urinary prostaglandin and sodium metabolism in patients with essential hypertension.
Minoru Yasujima+10 more
openalex +2 more sources
Interleukin‐1 receptor type II and inflammatory bowel disease: A Mendelian randomization study
This Mendelian Randomization study investigated the association between interleukin‐1 receptor type II (IL‐1RII) and inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC) by utilizing the genome‐wide association studies summary statistics.
Qifan Feng+7 more
wiley +1 more source
Diverse Lenabasum pathway activation in dermatomyositis patients' blood. [PDF]
Kodali N+11 more
europepmc +1 more source
A novel bimodal coated‐dissolving microneedle system is developed for extended transdermal delivery of diclofenac and dexamethasone nanoparticles. The formulation enables high drug loading, efficient skin penetration, and sustained release over 72 h, offering a minimally invasive, self‐administered therapy to improve osteoarthritis treatment by ...
Mingshan Li+8 more
wiley +1 more source